PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Applied Cell Sciences, Faculty of Basic Science and Advanced Medical Technologies, Royan Institute, ACECR, Tehran, Iran; Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven Stem Cell Institute, Leuven, Belgium; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research, ACECR, Tehran, Iran.\', \'Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research, ACECR, Tehran, Iran; Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.\', \'Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven Stem Cell Institute, Leuven, Belgium.\', \'Department of Applied Cell Sciences, Faculty of Basic Science and Advanced Medical Technologies, Royan Institute, ACECR, Tehran, Iran; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research, ACECR, Tehran, Iran. Electronic address: masvos@Royaninstitute.org.\', \'Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven Stem Cell Institute, Leuven, Belgium. Electronic address: Catherine.verfaillie@kuleuven.be.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1359-6446(21)00565-110.1016/j.drudis.2021.12.014
?:doi
?:hasPublicationType
?:journal
  • Drug discovery today
is ?:pmid of
?:pmid
?:pmid
  • 34954328
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.008
?:rankingScore_hIndex
  • 150
?:title
  • Organoid and microfluidics-based platforms for drug screening in COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all